1. Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial. Issue 10 (October 2017) Authors: Serie, Daniel J.; Crook, Julia E.; Necela, Brian M.; Dockter, Travis J.; Wang, Xue; Asmann, Yan W.; Fairweather, DeLisa; Bruno, Katelyn A.; Colon-Otero, Gerardo; Perez, Edith A.; Thompson, E. Aubrey; Norton, Nadine Journal: Pharmaocogenetics and genomics Issue: Volume 27:Issue 10(2017:Oct.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mayo Clinic Alix School of Medicine. (September 2020) Authors: Reed, Darcy A.; Harrison, M. Edwyn; Wolanskyj-Spinner, Alexandra P.; Dixon, Debbie A.; Halyard, Michele Y.; Colon-Otero, Gerardo; Andresen-Reid, Marcia L.; Meyer, Fredric B. Journal: Academic medicine Issue: Volume 95:Number 9S(2020)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Molecular genetic changes in solid pseudopapillary neoplasms (SPN) of the pancreas. (1st September 2020) Authors: Rodriguez-Matta, Elisa; Hemmerich, Amanda; Starr, Jason; Mody, Kabir; Severson, Eric A.; Colon-Otero, Gerardo Journal: Acta oncologica Issue: Volume 59:Number 9(2020) Page Start: 1024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin. Issue 1 (December 2016) Authors: Hall, Jason; Marlow, Laura; Mathias, Adam; Dawson, Louis; Durham, William; Meshaw, Kenneth; Mullin, Robert; Synnott, Aidan; Small, Daniel; Krishna, Murli; Hoff, Daniel; Schüler, Julia; Hart, Steven; Couch, Fergus; Colon-Otero, Gerardo; Copland, John Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers. Issue 5 (27th October 2020) Authors: Colon-Otero, Gerardo; Zanfagnin, Valentina; Hou, Xiaonan; Foster, Nathan R; Asmus, Erik J; Wahner Hendrickson, Andrea; Jatoi, Aminah; Block, Matthew S; Langstraat, Carrie L; Glaser, Gretchen E; Dinh, Tri A; Robertson, Matthew W; Camoriano, John K; Butler, Kristina A; Copland, John A; Weroha, S John Journal: ESMO open Issue: Volume 5:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers. Issue 5 (27th October 2020) Authors: Colon-Otero, Gerardo; Zanfagnin, Valentina; Hou, Xiaonan; Foster, Nathan R; Asmus, Erik J; Wahner Hendrickson, Andrea; Jatoi, Aminah; Block, Matthew S; Langstraat, Carrie L; Glaser, Gretchen E; Dinh, Tri A; Robertson, Matthew W; Camoriano, John K; Butler, Kristina A; Copland, John A; Weroha, S John Journal: ESMO open Issue: Volume 5:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers. Issue 5 (27th October 2020) Authors: Colon-Otero, Gerardo; Zanfagnin, Valentina; Hou, Xiaonan; Foster, Nathan R; Asmus, Erik J; Wahner Hendrickson, Andrea; Jatoi, Aminah; Block, Matthew S; Langstraat, Carrie L; Glaser, Gretchen E; Dinh, Tri A; Robertson, Matthew W; Camoriano, John K; Butler, Kristina A; Copland, John A; Weroha, S John Journal: ESMO open Issue: Volume 5:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗